|
HS Code |
733733 |
| generic_name | Tetracaine |
| brand_names | Pontocaine, Ametop |
| drug_class | Local anesthetic (Ester type) |
| chemical_formula | C15H24N2O2 |
| molecular_weight | 264.36 g/mol |
| route_of_administration | Topical, ophthalmic, injectable |
| mechanism_of_action | Blocks sodium ion channels, preventing nerve impulse conduction |
| onset_of_action | Rapid (within minutes) |
| duration_of_action | Short to moderate (approx. 15–30 minutes) |
| primary_uses | Local anesthesia for minor procedures, ophthalmic procedures, spinal anesthesia |
| appearance | White crystalline powder |
| CAS_number | 94-24-6 |
As an accredited Tetracaine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A sterile, sealed amber glass vial containing 25 grams of Tetracaine powder, clearly labeled with hazard warnings and usage instructions. |
| Shipping | Tetracaine is shipped in tightly sealed, appropriately labeled containers to prevent contamination and degradation. It requires protection from light and moisture, and is typically transported at controlled room temperature. All packages comply with regulatory guidelines for handling pharmaceuticals and chemicals, ensuring safe delivery to laboratories or medical facilities. |
| Storage | Tetracaine should be stored in a tightly closed container, protected from light, moisture, and incompatible substances. It should be kept at room temperature, ideally between 15°C and 30°C (59°F and 86°F). Storage areas must be well-ventilated and secure, away from heat sources and direct sunlight. Access should be limited to authorized personnel only. |
Applications of Tetracaine in Industrial ManufacturingTetracaine serves as a critical functional ingredient in several specialized industrial sectors, distinguished by stringent regulatory oversight and defined processing protocols. Our direct manufacturing capabilities ensure consistent supply and specification control, directly meeting the operational requirements of top industry players. Below are the primary downstream application scenarios for Tetracaine, each with its own compliance regimes, formulation specifics, manufacturing integration points, and market outputs. 1. Injectable Local Anesthetics ManufacturingPharmaceutical companies source Tetracaine for compounding sterile injectable anesthetic solutions, primarily for use in spinal and ophthalmic blocks. The ingredient requires precise dissolution and sterilization steps before aseptic filling. Dose and purity align with safety and therapeutic standards set by global regulatory bodies. Manufacturers integrate Tetracaine at controlled stages during solution compounding to achieve required pharmacological activity in the final product. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Topical Anesthetic Gel and Cream ProductionCosmeceutical and pharmaceutical manufacturers incorporate Tetracaine into topical gels and creams for fast-acting anesthesia in dermatology procedures, tattooing, and minor skin interventions. Formulators blend the active within emulsions or water-based gels, adjusting carrier systems to optimize penetration and onset time. Regulatory scrutiny in this segment mandates precise dosage verification and clinical documentation prior to distribution. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Ophthalmic Anesthetic Eye Drop FormulationSterile ophthalmic facilities source pure-grade Tetracaine for production of ocular anesthetic drops required in optometry and ophthalmic surgery. Manufacturers must maintain ultra-low contamination risk during formulation, and ensure rapid, uniform solution of the anesthetic in buffered saline carriers. Stability and isotonicity remain critical to meet ocular safety profiles governed by global pharmacopeias. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Dental Local Anesthetic Cartridge ManufacturingTetracaine functions as a key ingredient in high-potency local anesthetic cartridges used in dental clinics for procedures involving mucosal anesthesia. Pharmaceutical manufacturers incorporate the compound after rigorous aqueous solution standardization, often in multi-active blends, within precise primary packing lines. Stringent bioburden and dosing controls underpin regulatory certification for these invasive-use consumables. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Veterinary Regional Anesthesia Product FormulationAnimal health pharmaceutical firms apply Tetracaine in the manufacture of regional anesthesia injectable solutions, providing analgesia for surgical or diagnostic interventions in both companion animals and livestock. Processes must comply with veterinary drug safety frameworks, adapting human-grade standards for animal care requirements. Formulators select concentrations and carriers to fit target species metabolism, validated by veterinary clinical studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Tetracaine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing local anesthetics that do the job, batch after batch, takes more than just following a recipe. We start with Tetracaine, a compound that’s built its reputation over decades for reliability in pain management. By handling every step from synthesis to QA in-house, we keep control where it matters: purity, consistency, safety. Tetracaine leaves our facility only when the lot runs clean, meets analytic standards, and gives dependable results in application. No surprises, no confusion in content. This approach draws from our years on the manufacturing floor, running real equipment rather than copy-pasting chemical inventories.
Our line-up focuses on Tetracaine hydrochloride, with a molecular formula of C15H25ClN2O2. We deliver it white or nearly white crystalline powder, with a stated purity typically exceeding 99%. Moisture content stays low, below the half-percent mark. Loss on drying, residue on ignition, and heavy metal presence remain far beneath acceptable limits. Each batch comes with full chromatography backing, not just a label; if the specs tighten up over time, so does our process.
The feel and flow of the powder affect how it integrates into finished pharmaceutical forms. Good free-flowing particles take away headaches downstream during blending and tablet production. We check particle size distribution and adjust milling as needed, because a smooth-running line makes life easier for production chemists and gives pharmacists the behavior they expect at the bench.
Real stories from our customers have shaped how we make Tetracaine. Operating theaters call for strong, long-lasting anesthesia, not something that wears off before the sutures go in. Dentists and ophthalmologists rely on its numbing power for localized procedures where patient comfort and minimal toxicity go hand in hand. Tetracaine’s appeal comes from its potency and duration: it soaks into mucous membranes efficiently, holds back pain through minor surgeries, and sits at the backbone of spinal anesthesia mixes when other options fade too fast.
Manufacturing for injection and topical forms brings specific issues. Solubility and pH must match downstream needs. Slight pH missteps or foreign ion contamination throw off stability or open the door to irritation and unexpected reactions. We tackle these problems by tuning our washing and crystallization processes, keeping the chloride stable and leaving behind any process residues. We monitor parent compound and impurities well below regulatory tripwires—not just for compliance, but because lost batches hurt all the way down the chain.
Some folks ask why we keep Tetracaine at the center when lidocaine and procaine fill a lot of scripts. Here’s what we’ve seen firsthand. Lidocaine brings rapid onset, but its duration often comes up short for lengthy nerve blocks. Procaine shows a gentler profile, though its potency falls behind when procedures stretch on. Neither stands up in the same way during complex eye or spinal interventions. Tetracaine’s longer action and strength allow clinicians to manage pain more predictably during specialty work, even at lower concentrations.
We talk shop with pharmacists and researchers, hearing their questions about allergic reactions. Tetracaine, an ester anesthetic, does show rare sensitivity in specific patients, especially compared to amide types. This fact doesn’t push it aside. Instead, it calls for clear labeling and reliable purity—manufacturing without residues from raw chemicals or process solvents. We minimize cross-contaminants by using designated reactors and validated cleaning protocols.
Research isn’t just a formality—it’s the survival skill for any manufacturer looking to stay useful. Drug developers and generic producers share their pain points. Solubility issues, formulation headaches, and shelf-life questions drive us to tweak recrystallization steps and invest in better filtration setups. We don’t make decisions looking at spreadsheets alone. The best tweaks flow from responding to direct feedback and seeing what truly reduces formulation complaints.
Not all requests take weeks in pilot scale; some improvements happen in a single shift. Operators reading in-process results spot a drift in color or slight moisture rise, hit pause, and make adjustments. Those small decisions, rooted in practical shop-floor skill, keep our materials in line with modern pharmaceutical demands. Tetracaine’s applicability keeps growing because we actively watch the intersection of regulation, innovation, and practical experience, not just literature reviews.
Discussions around Tetracaine don’t ignore safety. The compound’s power brings risks if misused. Handling precautions are more than compliance paperwork. Our crews wear PPE not just because rules require it, but because we’ve seen what accidental exposure can do: skin numbness, eye irritation, and headaches from vapor. Spills and airborne dust might seem minor, yet overexposure during large-scale packaging became a tough lesson years ago. We doubled up on dust controls, optimized dust extraction systems, and trained our staff to respect Tetracaine’s potency.
Medical users trust documentation and material traceability from the source. Our records reach further back than the last run—each drum can be traced to shift crews, lot numbers, and even the lot numbers of precursor chemicals. We field regular audits, open our books and processes, and invite direct inspection because transparency builds the trust that keeps business honest.
Making Tetracaine isn’t just filling an order. Years of hands-on production leave us with a sharp sense of what end users actually deal with—buffers clumping in solution, heat instability, trace contaminants, odd odors, foaming during dissolution. These don’t show up in sales pitches, but we track and resolve each as part of the final product. Stubborn solvent traces? We tune washes and recycling loops. Unpredictable flow? We refine particle engineering. Performance under light and temperature swings? We work with partners to study and upgrade packaging solutions.
We don’t shrink from customers pointing out failed batches or out-of-spec vials; these early warnings prevent larger recalls. Instead of sidestepping, we build every error into process updates and operator training. Our chemists and plant operators experience the process in real time—handling Tetracaine isn’t abstract to us.
One issue that seldom gets enough daylight remains waste handling. Tetracaine production, like all ester compound syntheses, produces aqueous and organic waste streams. Regulations shift, but our methods keep evolving faster than the paperwork. Closed-loop solvent recovery lessens our environmental load and cuts the risk of batch-to-batch contamination. Analysts monitor trace emissions in real time, signaling maintenance needs to protect both workers and the broader community.
We battle yield loss every day, too. In one quarter, process tweaks to rinsing and solvent handling returned over a hundred kilos of viable product that, in earlier years, would have gone to disposal. Multiply this saving across a year, and the reduced waste equals hundreds of fewer barrels needing hazardous treatment each cycle.
Tetracaine can look routine on paper, but details set products apart. Some suppliers cut corners—running outdated dryers, skipping robust impurity checks, or skimping on operator training. Our approach values full, regular maintenance of crystallizers, fresh calibration on all chromatography machines, ongoing analytical chemist training, and direct oversight of each step. Following international pharmacopoeia standards, not just for box-ticking but for real risk reduction in delivered product, we’ve built a record clear to every QA inspector walking our floor.
In discussions with partners, questions about cross contamination or unexpected impurity spikes always surface. Our answer: separate reactor lines and real-time impurity tracking. Still, experience remains a living thing. Even the best schemes fail without vigilant operators reading data, understanding every process signature, and communicating directly on each shift.
With anesthetics like Tetracaine, simplicity on paper often hides complexity in real life. Raw material quality swings wildly, especially during supply disruptions or global resin shortages. Staying hands-on lets us respond before problems snowball into customer pain. A lot arriving outside our acceptance bands means direct calls, reprocessing, or finding a parallel lot—never just blending or diluting down to spec. That attitude leads to fewer late surprises for downstream formulators who already have their hands full balancing cost, compliance, and dose accuracy.
Seen from the shop floor, lean manufacturing matters less as a slogan and more as a constant fight against waste, errors, and weak process controls. The winning edge doesn’t come from copying SOPs off the shelf, but living through each process run, learning both from near-misses and above-benchmark batches.
Clinicians and researchers still find new applications and improvements around Tetracaine as processes push forward. Controlled storage conditions—cool, dry, and shielded from strong light—keep stability strong for years, but only if distribution links hold up. We ship only under compliant conditions, monitor transit, and avoid third-party shortcuts in labeling, to guarantee what arrives has the same profile as what left our dock. Failures in the cold chain or simple humidity breaches can throw off the expected composition. Here, quality assurance runs end to end—a chain built on details, not assumptions.
As regulatory reviews evolve, our documentation grows. Each change to process or equipment means updated paperwork, new in-process checks, and ongoing discussions with regulators and partners. The learning never stops, and that’s by design. Every audit, inquiry or even informal chat with a long-time researcher brings us a new way to improve, refine, or spot problems before they escalate.
From our time producing Tetracaine at commercial scale, the real lessons lie less in lab-generated data and more in operational discipline. Random spot testing, anonymized product reviews, and long-term stability trials keep our focus on the big picture: reliability at each stage, from raw material to patient-ready form. Analytical chemistry evolves; we ride those innovations and invest in next-generation detection to stay ahead. Our customers—manufacturing pharmacists, medical buyers, research institutes—count on us not to drift, get complacent, or cut costs at the wrong time.
Handling regulatory pressure, market risk, and shifting clinical guidelines means adaptability. Surging demand for sterile injectables or new topical forms triggers recalibration in both production and quality control. Ongoing training, investment in plant upgrades, and open lines of communication with partners steer us clear of stagnation. We take nothing for granted, especially in a sector where lives depend on the quiet certainty that each dose matches the last.
Out on the factory floor, between raw chemical deliveries and the final drum shipped out, the story of Tetracaine becomes real in every test, tweak, and troubleshooting session. Reliability means more than a specification sheet or a compliance certificate. Decades of producing this compound have taught us to respect its power, to be transparent about its risks, and to invest in continual improvement—both in chemistry and in the human element that runs every process.
We believe the real value in Tetracaine comes not just from its well-known clinical effects, but from the commitment to craft, discipline, and open conversation that keeps our product a mainstay across challenging pharmaceutical applications. Instead of chasing novelty for its own sake, we return to fundamentals: build clean, test rigorously, listen to feedback, and respond quickly. That’s our ongoing promise to the clinics, researchers, and manufacturers relying on our work each day.